Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
Frontiers in Pediatrics|February 22, 2021
Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes MellitusConstance Carels, Lucas Wauters, An Outtier, et al.Transplantation|August 1, 2019
Heterogeneity of Human Pancreatic Islet Isolation Around Europe: Results of a Survey StudyRita Nano, Julie A Kerr-Conte, Hanne Scholz, et al.Diabetes Care|February 4, 2025
Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal AnalysisAster K Desouter, Bart Keymeulen, Ursule Van de Velde, et al.Diabetes|July 16, 2009
Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patientsRobert Hilbrands, Volkert A L Huurman, Pieter Gillard, et al.The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthoodIlse Weets, Valerie Siraux, Jean-Claude Daubresse, et al.Journal of Autoimmunity|June 4, 2011
Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimersWendy W Unger, Jurjen Velthuis, Joana R F Abreu, et al.Diabetes Technology & Therapeutics|December 30, 2025
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 DiabetesJolien De Meulemeester, Francesca Fiorentino, Nuno Picado, et al.The New England Journal of Medicine|June 24, 2005
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetesBart Keymeulen, Evy Vandemeulebroucke, Anette G Ziegler, et al.Plos One|June 19, 2008
Cellular islet autoimmunity associates with clinical outcome of islet cell transplantationVolkert A L Huurman, Robert Hilbrands, Gabriëlle G M Pinkse, et al.The Journal of Clinical Endocrinology and Metabolism|August 17, 2006
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetesGary A Herman, Arthur Bergman, Catherine Stevens, et al.Pageof 10